Reactive Oxygen Species-Mediated Inflammation and Apoptosis in Hand-Foot Syndrome Induced by PEGylated Liposomal Doxorubicin

Xiaolin Hu,1,2 Mengmeng Dong,2 Xiao Liang,2 Ziling Liu,1 Quanshun Li2 1Cancer Center, The First Hospital of Jilin University, Changchun 130012, People’s Republic of China; 2Key Laboratory for Molecular Enzymology and Engineering of Ministry of Education, School of Life Sciences, Jilin Univ...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Hu X, Dong M, Liang X, Liu Z, Li Q
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	pegylated liposomal doxorubicin hand-foot syndrome reactive oxygen species skin lesion Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/201785a22b6e459db1bb51dca4734128
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:201785a22b6e459db1bb51dca4734128
record_format	dspace
spelling	oai:doaj.org-article:201785a22b6e459db1bb51dca47341282021-12-02T13:43:58ZReactive Oxygen Species-Mediated Inflammation and Apoptosis in Hand-Foot Syndrome Induced by PEGylated Liposomal Doxorubicin1178-2013https://doaj.org/article/201785a22b6e459db1bb51dca47341282021-01-01T00:00:00Zhttps://www.dovepress.com/reactive-oxygen-species-mediated-inflammation-and-apoptosis-in-hand-fo-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Xiaolin Hu,1,2 Mengmeng Dong,2 Xiao Liang,2 Ziling Liu,1 Quanshun Li2 1Cancer Center, The First Hospital of Jilin University, Changchun 130012, People’s Republic of China; 2Key Laboratory for Molecular Enzymology and Engineering of Ministry of Education, School of Life Sciences, Jilin University, Changchun 130012, People’s Republic of ChinaCorrespondence: Quanshun Li; Ziling Liu Tel +86-431-85155201Fax +86-431-85155200Email quanshun@jlu.edu.cn; ziling@jlu.edu.cnBackground: Doxil® (PEGylated liposomal doxorubicin, PLD) has been widely used in cancer treatment due to its excellent therapeutic efficacy, but it can simultaneously cause severe adverse effects such as hand-foot syndrome (HFS). To date, the pathophysiologic mechanism of HFS development induced by PLD administration has not been well understood.Materials and Methods: The histological features of skin lesion in PLD-induced HFS model were characterized by hematoxylin and eosin (H&E) staining and picrosirius red staining, and the induction of inflammation and apoptosis in the epidermal layer was detected by immunohistochemical and TUNEL staining. Moreover, the generation of reactive oxygen species (ROS) was determined to elucidate the potential mechanism of skin lesion in the development of HFS.Results: The administration of PLD has been demonstrated to induce the histological damage of skin tissues including the destruction of collagen fibers and the induction of severe inflammation and apoptosis of epidermal cells. The mechanism was probably attributed to the accumulation of PLD in the skin tissues during the long-term circulation and further the induction of ROS to cause the oxidative damage of keratinocytes owing to the sustained release of doxorubicin from PLD.Conclusion: The ROS generation induced by the administration of PLD has been identified to be a crucial factor in the development of HFS, which could be used as a potential therapeutic target to alleviate the HFS symptom of PLD administration.Keywords: PEGylated liposomal doxorubicin, hand-foot syndrome, reactive oxygen species, skin lesionHu XDong MLiang XLiu ZLi QDove Medical Pressarticlepegylated liposomal doxorubicinhand-foot syndromereactive oxygen speciesskin lesionMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 16, Pp 471-480 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	pegylated liposomal doxorubicin hand-foot syndrome reactive oxygen species skin lesion Medicine (General) R5-920
spellingShingle	pegylated liposomal doxorubicin hand-foot syndrome reactive oxygen species skin lesion Medicine (General) R5-920 Hu X Dong M Liang X Liu Z Li Q Reactive Oxygen Species-Mediated Inflammation and Apoptosis in Hand-Foot Syndrome Induced by PEGylated Liposomal Doxorubicin
description	Xiaolin Hu,1,2 Mengmeng Dong,2 Xiao Liang,2 Ziling Liu,1 Quanshun Li2 1Cancer Center, The First Hospital of Jilin University, Changchun 130012, People’s Republic of China; 2Key Laboratory for Molecular Enzymology and Engineering of Ministry of Education, School of Life Sciences, Jilin University, Changchun 130012, People’s Republic of ChinaCorrespondence: Quanshun Li; Ziling Liu Tel +86-431-85155201Fax +86-431-85155200Email quanshun@jlu.edu.cn; ziling@jlu.edu.cnBackground: Doxil® (PEGylated liposomal doxorubicin, PLD) has been widely used in cancer treatment due to its excellent therapeutic efficacy, but it can simultaneously cause severe adverse effects such as hand-foot syndrome (HFS). To date, the pathophysiologic mechanism of HFS development induced by PLD administration has not been well understood.Materials and Methods: The histological features of skin lesion in PLD-induced HFS model were characterized by hematoxylin and eosin (H&E) staining and picrosirius red staining, and the induction of inflammation and apoptosis in the epidermal layer was detected by immunohistochemical and TUNEL staining. Moreover, the generation of reactive oxygen species (ROS) was determined to elucidate the potential mechanism of skin lesion in the development of HFS.Results: The administration of PLD has been demonstrated to induce the histological damage of skin tissues including the destruction of collagen fibers and the induction of severe inflammation and apoptosis of epidermal cells. The mechanism was probably attributed to the accumulation of PLD in the skin tissues during the long-term circulation and further the induction of ROS to cause the oxidative damage of keratinocytes owing to the sustained release of doxorubicin from PLD.Conclusion: The ROS generation induced by the administration of PLD has been identified to be a crucial factor in the development of HFS, which could be used as a potential therapeutic target to alleviate the HFS symptom of PLD administration.Keywords: PEGylated liposomal doxorubicin, hand-foot syndrome, reactive oxygen species, skin lesion
format	article
author	Hu X Dong M Liang X Liu Z Li Q
author_facet	Hu X Dong M Liang X Liu Z Li Q
author_sort	Hu X
title	Reactive Oxygen Species-Mediated Inflammation and Apoptosis in Hand-Foot Syndrome Induced by PEGylated Liposomal Doxorubicin
title_short	Reactive Oxygen Species-Mediated Inflammation and Apoptosis in Hand-Foot Syndrome Induced by PEGylated Liposomal Doxorubicin
title_full	Reactive Oxygen Species-Mediated Inflammation and Apoptosis in Hand-Foot Syndrome Induced by PEGylated Liposomal Doxorubicin
title_fullStr	Reactive Oxygen Species-Mediated Inflammation and Apoptosis in Hand-Foot Syndrome Induced by PEGylated Liposomal Doxorubicin
title_full_unstemmed	Reactive Oxygen Species-Mediated Inflammation and Apoptosis in Hand-Foot Syndrome Induced by PEGylated Liposomal Doxorubicin
title_sort	reactive oxygen species-mediated inflammation and apoptosis in hand-foot syndrome induced by pegylated liposomal doxorubicin
publisher	Dove Medical Press
publishDate	2021
url	https://doaj.org/article/201785a22b6e459db1bb51dca4734128
work_keys_str_mv	AT hux reactiveoxygenspeciesmediatedinflammationandapoptosisinhandfootsyndromeinducedbypegylatedliposomaldoxorubicin AT dongm reactiveoxygenspeciesmediatedinflammationandapoptosisinhandfootsyndromeinducedbypegylatedliposomaldoxorubicin AT liangx reactiveoxygenspeciesmediatedinflammationandapoptosisinhandfootsyndromeinducedbypegylatedliposomaldoxorubicin AT liuz reactiveoxygenspeciesmediatedinflammationandapoptosisinhandfootsyndromeinducedbypegylatedliposomaldoxorubicin AT liq reactiveoxygenspeciesmediatedinflammationandapoptosisinhandfootsyndromeinducedbypegylatedliposomaldoxorubicin
_version_	1718392483537223680

Reactive Oxygen Species-Mediated Inflammation and Apoptosis in Hand-Foot Syndrome Induced by PEGylated Liposomal Doxorubicin

Ejemplares similares